11 – 20 of 112
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Collaboration on the optimal timing of anticoagulation after ischaemic stroke and atrial fibrillation : a systematic review and prospective individual participant data meta-analysis of randomised controlled trials (CATALYST)
- Contribution to journal › Article
-
Mark
Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): a multicentre, open-label, randomised, phase 3 trial
- Contribution to journal › Article
- 2024
-
Mark
Halving premature death and improving quality of life at all ages : cross-country analyses of past trends and future directions
- Contribution to journal › Article
-
Mark
First dose of misoprostol administration at home or in hospital for medical abortion between 12–22 gestational weeks in Sweden (PRIMA) : a multicentre, open-label, randomised controlled trial
- Contribution to journal › Article
-
Mark
Haemodiafiltration versus haemodialysis for kidney failure : an individual patient data meta-analysis of randomised controlled trials
- Contribution to journal › Article
-
Mark
Optimal timing of anticoagulation after acute ischaemic stroke with atrial fibrillation (OPTIMAS): a multicentre, blinded-endpoint, phase 4, randomised controlled trial
- Contribution to journal › Article
-
Mark
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
- Contribution to journal › Article
-
Mark
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
- Contribution to journal › Article
-
Mark
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
- Contribution to journal › Article
-
Mark
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
- Contribution to journal › Article